Search

everythinglearnresearchcommunity

for

Search:↓

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

JAK inhibitors offer new hope for treating severe alopecia areata.

Gut bacteria differences may help diagnose and treat Alopecia areata.

A woman's hair loss led to discovering she had lupus.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Infliximab may cause hair loss in Crohn's disease patients.

UV light helped human hair transplants survive in mice without broad immunosuppression.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Baricitinib may effectively treat nail changes in alopecia areata.